The authors describe a localized toxicity syndrome that is associated with immunotherapy treatment for CNS tumors and propose a new grading scale—with the goal of promoting research and standardizing both reporting and management.
- Jasia Mahdi
- Jorg Dietrich
- Michelle Monje
